Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Cell And Gene Therapy Supply Chain/Logistics Market Covering 2025–2034?
The cell and gene therapy supply chain/logistics market has experienced significant expansion recently. Projections indicate this market will expand from $1.41 billion in 2024 to reach $1.57 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 11.5%. This historical growth is attributable to factors such as an increasing prevalence of chronic diseases, the efficient application of supply chain necessities, improved methods for maintaining drug integrity, the development of regulatory frameworks, and a heightened focus on risk mitigation and compliance.
The cell and gene therapy supply chain/logistics market is projected for significant expansion in the coming years. This market is predicted to reach $2.44 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.5%. Key factors contributing to this anticipated growth include the increasing scope of personalized medicine, advancements in cell-free therapies, the rising incidence of chronic diseases, the expanding global cell therapy manufacturing market, and the effective implementation of supply chain necessities. Noteworthy trends during the forecast period encompass elevated spending on research and development, the integration of cutting-edge technologies, supportive initiatives and programs designed to improve accessibility, strategic alliances and partnerships among cell and gene therapy firms, supply chain vendors, and logistics providers, and the offering of tailored services to assist at every stage of patient identification.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp
What Are The Top Growth Drivers Impacting The Cell And Gene Therapy Supply Chain/Logistics Market Outlook?
The rising demand for cell and gene therapies is propelling the cell and gene therapy supply chain or logistics market. These therapies are sophisticated medical interventions that involve altering cells or genes to address illnesses, presenting promising solutions for previously incurable conditions. Proper temperature and storage conditions are crucial for these cell and gene therapies, a requirement met by supply chain and logistics services that assist with everything from their sourcing to distribution and storage. As an illustration, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported a 10% increase in gene therapies in Phase III clinical trials during Q3 2023, marking the first quarterly rise since Q3 2022. Consequently, the growing demand for cell and gene therapies is advancing the cell and gene therapy supply chain or logistics market.
What Are The Primary Types Of Segments Analyzed In The Cell And Gene Therapy Supply Chain/Logistics Market?
The cell and gene therapy supply chain/logisticsmarket covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform; Enterprise Manufacturing System; Inventory Management System; Laboratory Information Management System; Logistics Management System; Patient Management System; Quality Management System; Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution; On-Premises Solution
3) By Component: Cryogenic Shippers; Cryogenic Storage Freezers; Ultra-Low Freezers; Cold Chain Management Systems; Shipment; Storage Medium; Cryogenic Packout Kits; Other Components
4) By Application Area: Donor Eligibility Assessment; Sample Collection; Manufacturing; Logistics; Patient Verification; Treatment Follow-Up
5) By End User: Biobank; Cell Therapy Lab; Hospital; Research Institute; Commercial Organization
Subsegments:
1) By Cell Orchestration Platform: Workflow Management; Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control; Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management; Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management; Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning; Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination; Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking; Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments; Chain Of Custody Documentation
What Trends Are Redefining The Cell And Gene Therapy Supply Chain/Logistics Market Dynamics?
Advanced technological platforms are emerging as a significant trend gaining traction across the cell and gene therapy supply chain and logistics markets. Key companies active in this sector are developing sophisticated technology platforms for cell and gene therapies to secure their market presence. For instance, in April 2023, AmerisourceBergen Corporation., a US-based healthcare company specializing in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. This Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s innovative customer relationship management (CRM) system. It can be seamlessly integrated into the biopharma platform to provide improved oversight of the development and delivery of cell and gene therapies.
Who Are The Major Companies Operating In The Cell And Gene Therapy Supply Chain/Logistics Market?
Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
Download The Full Report For Exclusive Market Findings:
What Regional Growth Trends Are Shaping The Cell And Gene Therapy Supply Chain/Logistics Market Outlook?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Cell And Gene Therapy Supply Chain/Logistics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12631&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Supply Chain/Logistics Market 2025, By The Business Research Company
Cell And Gene Therapy Manufacturing Services Global Market Report 2025
Genes Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Gene Editing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model